Fougera and Protherics announce increased DigiFab production to counteract shortage.
Fougera and Protherics, Inc. have announced an increase in production of their digoxin immune fab (ovine) (
Q&A: How Specific GLP-1s Impact Different Patient Populations | ASHP Midyear
Jennifer Clements, PharmD, BCACP, BC-ADM, BCPS, CDCES, FADCES, FCCP, discussed current GLP-1 medication offerings and how each impacts patients differently.